STOCK TITAN
  1. Home
  2. Sec-filings
  3. PSTV
  4. [ARS] PLUS THERAPEUTICS, INC. SEC Filing

[ARS] PLUS THERAPEUTICS, INC. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - PLUS THERAPEUTICS, INC.

ARS Filing - PLUS THERAPEUTICS, INC.

This filing is available as a PDF document.

Filing Type: ARS

Company: PLUS THERAPEUTICS, INC. (PSTV)

Acceptance Date: 2026-03-31T16:25:04.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Plus Therapeutics Inc

NASDAQ:PSTV

View PSTV Stock Overview →

PSTV Rankings

#5781 Ranked by Market Cap
N/A Ranked by Dividends
#30 Top Loser

PSTV Latest News

Mar 31, 2026
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mar 31, 2026
Plus Therapeutics Announces Reverse Stock Split 
Mar 26, 2026
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
Mar 19, 2026
Plus Therapeutics to Present New Analysis at ISPOR Showing CNSide® May Reduce Leptomeningeal Metastases Healthcare Costs by 40%
Mar 12, 2026
Plus Therapeutics Reports 2025 Results, Business Progress and 2026 Anticipated Milestones for REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

PSTV Latest SEC Filings

Apr 1, 2026
[Form 4] PLUS THERAPEUTICS, INC. Insider Trading Activity
Apr 1, 2026
[Form 4] PLUS THERAPEUTICS, INC. Insider Trading Activity
Mar 31, 2026
[DEF 14A] PLUS THERAPEUTICS, INC. Definitive Proxy Statement
Mar 30, 2026
[Form 3] PLUS THERAPEUTICS, INC. Initial Statement of Beneficial Ownership
Mar 26, 2026
[8-K] PLUS THERAPEUTICS, INC. Reports Material Event

PSTV Stock Data

36.81M
169.42M
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
AUSTIN